This is a Validated Antibody Database (VAD) review about mouse Fgfr4, based on 6 published articles (read how Labome selects the articles), using Fgfr4 antibody in all methods. It is aimed to help Labome visitors find the most suited Fgfr4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Fgfr4 synonym: Fgfr-4

Knockout validation
Santa Cruz Biotechnology
mouse monoclonal (A-10)
  • western blot knockout validation; human; loading ...; fig s1
Santa Cruz Biotechnology Fgfr4 antibody (Santa Cruz Biotechnology, sc-136988) was used in western blot knockout validation on human samples (fig s1). Cancers (Basel) (2020) ncbi
Santa Cruz Biotechnology
mouse monoclonal (A-10)
  • western blot knockout validation; human; loading ...; fig s1
Santa Cruz Biotechnology Fgfr4 antibody (Santa Cruz Biotechnology, sc-136988) was used in western blot knockout validation on human samples (fig s1). Cancers (Basel) (2020) ncbi
mouse monoclonal (A-10)
  • western blot; human
Santa Cruz Biotechnology Fgfr4 antibody (Santa Cruz, SC-136988) was used in western blot on human samples . J Thyroid Res (2014) ncbi
mouse monoclonal (A-10)
  • western blot; hamsters
Santa Cruz Biotechnology Fgfr4 antibody (Santa Cruz, sc-136988) was used in western blot on hamsters samples . Protein Expr Purif (2014) ncbi
Abcam
domestic rabbit monoclonal
  • western blot; human; 1:500; loading ...; fig 2k
Abcam Fgfr4 antibody (Abcam, ab178396) was used in western blot on human samples at 1:500 (fig 2k). Aging (Albany NY) (2021) ncbi
mouse monoclonal (5B5)
  • flow cytometry; human; 1:100
  • immunocytochemistry; human; 1:100
Abcam Fgfr4 antibody (Abcam, ab44971) was used in flow cytometry on human samples at 1:100 and in immunocytochemistry on human samples at 1:100. PLoS ONE (2013) ncbi
Invitrogen
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 8e
Invitrogen Fgfr4 antibody (Invitrogen, PA5-105531) was used in western blot on mouse samples (fig 8e). Sci Rep (2021) ncbi
Articles Reviewed
  1. Guo T, Gu C, Li B, Xu C. Dual inhibition of FGFR4 and BCL-xL inhibits multi-resistant ovarian cancer with BCL2L1 gain. Aging (Albany NY). 2021;13:19750-19759 pubmed publisher
  2. Homer Bouthiette C, Xiao L, Hurley M. Gait disturbances and muscle dysfunction in fibroblast growth factor 2 knockout mice. Sci Rep. 2021;11:11005 pubmed publisher
  3. Alijaj N, Moutel S, Gouveia Z, Gray M, Roveri M, Dzhumashev D, et al. Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma. Cancers (Basel). 2020;12: pubmed publisher
  4. Tohyama O, Matsui J, Kodama K, Hata Sugi N, Kimura T, Okamoto K, et al. Antitumor activity of lenvatinib (e7080): an angiogenesis inhibitor that targets multiple receptor tyrosine kinases in preclinical human thyroid cancer models. J Thyroid Res. 2014;2014:638747 pubmed publisher
  5. Sokolowska Wedzina A, Borek A, Chudzian J, Jakimowicz P, Zakrzewska M, Otlewski J. Efficient production and purification of extracellular domain of human FGFR-Fc fusion proteins from Chinese hamster ovary cells. Protein Expr Purif. 2014;99:50-7 pubmed publisher
  6. Zuliani T, Saiagh S, Knol A, Esbelin J, Dreno B. Fetal fibroblasts and keratinocytes with immunosuppressive properties for allogeneic cell-based wound therapy. PLoS ONE. 2013;8:e70408 pubmed publisher